Page last updated: 2024-08-26

fulvestrant and apigenin

fulvestrant has been researched along with apigenin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H	1
Bigsby, RM; Fan, M; Long, X; Nephew, KP	1

Other Studies

2 other study(ies) available for fulvestrant and apigenin

Article	Year
Identifying off-target effects and hidden phenotypes of drugs in human cells. Nature chemical biology, 2006, Volume: 2, Issue:6 Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship	2006
Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms. Molecular cancer therapeutics, 2008, Volume: 7, Issue:7 Topics: Apigenin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Fluorescence Recovery After Photobleaching; Fulvestrant; Genes, Reporter; Histone Acetyltransferases; Humans; Hydroxytestosterones; Nuclear Receptor Coactivator 3; Protein Binding; Protein Kinases; Protein Transport; Trans-Activators; Transcription, Genetic	2008

Article

Year

Identifying off-target effects and hidden phenotypes of drugs in human cells.

Nature chemical biology, 2006, Volume: 2, Issue:6

Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006

Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms.

Molecular cancer therapeutics, 2008, Volume: 7, Issue:7

Topics: Apigenin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Fluorescence Recovery After Photobleaching; Fulvestrant; Genes, Reporter; Histone Acetyltransferases; Humans; Hydroxytestosterones; Nuclear Receptor Coactivator 3; Protein Binding; Protein Kinases; Protein Transport; Trans-Activators; Transcription, Genetic

2008